Ascendis Pharma A/S company logo
Ascendis Pharma A/S logo

Ascendis Pharma A/S (ASND) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$582.24M$148.75M+34.31%

Summary

Current Value
As of today, ASND annual cash & cash equivalents is $582.24M, up +34.31% on
Historical Performance
ASND annual cash & cash equivalents is up +15.23% over the past 3 years, and down -13.10% over the past 5 years
All-Time High Comparison
ASND annual cash & cash equivalents is currently -19.01% below its historical high of $718.93M set on
3-Year Low Comparison
ASND annual cash & cash equivalents is +34.31% above its 3-year low of $433.50M reached on
Sector Comparison
ASND annual cash & cash equivalents is higher than 90.42% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

ASND Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$582.24M+34.3%+15.2%-13.1%+2766.2%
Quarterly Cash & Cash Equivalents$633.43M-9.3%-29.7%-41.9%
Price$215.05+60.4%+87.0%+29.9%
Annual Current Assets$1.10B+42.1%+21.0%+61.2%+4641.5%
Annual Total Liabilities$1.33B+24.0%+481.4%+1389.1%+4449.2%
Annual Working Capital$158.43M-71.6%-80.3%-74.9%+2881.0%
Annual Net Income-$408.97M+21.4%+9.8%-67.6%

Cash and Cash Equivalents Highs

ASND Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$582.24Mat high
5Y$718.93MN/A-19.0%
All$718.93M-19.0%

Cash and Cash Equivalents Lows

ASND Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$433.50M+34.3%
5Y$433.50M+34.3%
All$19.22M+2929.0%

Cash and Cash Equivalents History

YearValueChange
$582.24M+34.3%
$433.50M-9.1%
$476.97M-5.6%
$505.27M-29.7%
$718.93M+7.3%
$669.98M+110.8%
$317.85M+35.6%
YearValueChange
$234.36M+22.9%
$190.64M+45.7%
$130.81M+114.4%
$61.00M+127.4%
$26.83M+39.6%
$19.22M-5.4%
$20.31M-

FAQ

  • What is the current annual cash & cash equivalents of ASND?

    As of today, ASND annual cash & cash equivalents is $582.24M

  • What is 1-year change in ASND annual cash & cash equivalents?

    ASND annual cash & cash equivalents is up +34.31% year-over-year

  • What is 3-year change in ASND annual cash & cash equivalents?

    ASND annual cash & cash equivalents is up +15.23% over the past 3 years

  • How far is ASND annual cash & cash equivalents from its all-time high?

    ASND annual cash & cash equivalents is currently -19.01% below its historical high of $718.93M set on December 31, 2020

  • How does ASND annual cash & cash equivalents rank versus sector peers?

    ASND annual cash & cash equivalents is higher than 90.42% of companies in Healthcare sector

  • When is ASND next annual earnings release?

    The next annual earnings release for ASND is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. ASND Official Website ascendispharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1612042/000119312525277622/0001193125-25-277622-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1612042/000095017025018852/0000950170-25-018852-index.htm
  4. ASND Profile on Yahoo Finance finance.yahoo.com/quote/ASND
  5. ASND Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/asnd